Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

U.S. FDA approves Janssen’s TREMFYA for the treatment of moderate to severe plaque psoriasis

biospectrumasiaJuly 18, 2017

Tag: Janssen , plaque psoriasis

PharmaSources Customer Service